Evaluating fatigue in patients with psoriatic arthritis and psoriasis
Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients
NA · Centre Hospitalier Henri Duffaut - Avignon · NCT06101706
This study is trying to see how fatigue affects the daily lives of adults with psoriatic arthritis and psoriasis to help improve their care.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Henri Duffaut - Avignon (other) |
| Locations | 1 site (Avignon) |
| Trial ID | NCT06101706 on ClinicalTrials.gov |
What this trial studies
This study assesses the levels of fatigue and quality of life in patients suffering from psoriatic arthritis and cutaneous psoriasis. It involves evaluating the severity of both conditions in patients over 18 years old who are being followed in rheumatology or dermatology departments. The study aims to gather data on how these diseases impact daily living and overall well-being. By understanding the relationship between fatigue and these conditions, the study seeks to inform better management strategies.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with any stage of psoriatic arthritis or any form of cutaneous psoriasis being treated in a specialized center.
Not a fit: Patients with other autoimmune diseases, severe comorbidities, or those under legal protection may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment strategies for patients suffering from fatigue associated with psoriatic arthritis and psoriasis.
How similar studies have performed: While there have been studies on fatigue in chronic conditions, this specific focus on psoriatic arthritis and psoriasis is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient over 18 years old. * Patient with psoriatic arthritis of any stage or duration, followed in the center's rheumatology or dermatology departments, whether or not treated with systemic therapy. * Patient with all forms of cuteaneous psoriasis (plaque, inverted, erythrodermic or guttate), whatever the stage or duration of the disease, followed in the center's dermatology department, whether or not treated with systemic therapy. Exclusion Criteria: * Patient with auto-inflammatory joint disease: ankylosing spondylitis, rheumatoid arthritis. * Patient with auto-immune disease involving skin lesions: lupus, dermatomyositis, morphea, pemphigus, pemphigoid, Sjögren's syndrome. * Cancer. * Pregnant women. * Severe heart failure (New York Heart Association Class III or IV). * Severe renal failure (DFG \< 30). * Hepatic failure. * Anemia \< 10g/dL. * Patient under legal protection, deprived of liberty or unable to be included in a research protocol.
Where this trial is running
Avignon
- Centre Hospitalier d'Avignon — Avignon, France (RECRUITING)
Study contacts
- Principal investigator: Carina Mihu, Medical Intern — Centre Hospitalier d'Avignon, Service de dermatologie
- Study coordinator: Maryline Grinand, PhD
- Email: grinand.marilyne@ch-avignon.fr
- Phone: (+33)432759392
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Psoriatic Arthritis, Psoriasis, Fatigue, Quality of life